Literature DB >> 9790507

Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site.

M A Prasad1, T M Trybus, K J Wojno, J A Macoska.   

Abstract

By using tissue microdissection and polymerase chain reaction (PCR) techniques, we examined 85 prostate tumors that were paired with normal tissues from the same patients for allelic loss at 26 highly polymorphic microsatellite sequences, 21 spanning 8p and 5 localized to 8q. Sixty-four tumors (75%) demonstrated loss of at least one 8p locus. Separate distal and proximal regions of deletion were observed as well as an intervening, staggered breakpoint. A novel region of homozygous deletion of sequences at the D8S87 locus was detected both by multiplex PCR and by fluorescence in situ hybridization within this breakpoint region. These data suggest that a tumor-suppressor gene mapping to proximal 8p is deleted frequently and is likely to be important for tumorigenesis in prostate tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790507

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.

Authors:  Z H Arbieva; K Banerjee; S Y Kim; S L Edassery; V S Maniatis; S K Horrigan; C A Westbrook
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

2.  Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23.

Authors:  J Xu; S L Zheng; G A Hawkins; D A Faith; B Kelly; S D Isaacs; K E Wiley; B Chang ; C M Ewing; P Bujnovszky; J D Carpten; E R Bleecker; P C Walsh; J M Trent; D A Meyers; W B Isaacs
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

3.  Genetic pathways and new progression markers for prostate cancer defined by microsatellite allelotyping.

Authors:  Rolf von Knobloch; Lutz Konrad; Peter J Barth; Heidrun Brandt; Sebastian Wille; Axel Heidenreich; Roland Moll; Rainer Hofmann
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

4.  Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?

Authors:  R Shah; N R Mucci; A Amin; J A Macoska; M A Rubin
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

5.  A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

Authors:  Lawrence D True; Kent Buhler; Janna Quinn; Emily Williams; Peter S Nelson; Nigel Clegg; Jill A Macoska; Thomas Norwood; Alvin Liu; William Ellis; Paul Lange; Robert Vessella
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression.

Authors:  Yuyan Zhu; Yuanyuan Li; Seiki Haraguchi; Meng Yu; Miki Ohira; Toshinori Ozaki; Atsuko Nakagawa; Toshikazu Ushijima; Eriko Isogai; Haruhiko Koseki; Yohko Nakamura; Cuize Kong; Patrick Mehlen; Hirofumi Arakawa; Akira Nakagawara
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

7.  Functional analysis of the host defense peptide Human Beta Defensin-1: new insight into its potential role in cancer.

Authors:  Rebecca S Bullard; Willietta Gibson; Sudeep K Bose; Jamila K Belgrave; Andre C Eaddy; Corey J Wright; Debra J Hazen-Martin; Janice M Lage; Thomas E Keane; Tomas A Ganz; Carlton D Donald
Journal:  Mol Immunol       Date:  2007-09-14       Impact factor: 4.407

Review 8.  tRNA modifications regulate translation during cellular stress.

Authors:  Chen Gu; Thomas J Begley; Peter C Dedon
Journal:  FEBS Lett       Date:  2014-10-07       Impact factor: 4.124

9.  Down-regulation of Lsm1 is involved in human prostate cancer progression.

Authors:  S Takahashi; S Suzuki; S Inaguma; Y-M Cho; Y Ikeda; N Hayashi; T Inoue; Y Sugimura; N Nishiyama; T Fujita; T Ushijima; T Shirai
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

10.  A human tRNA methyltransferase 9-like protein prevents tumour growth by regulating LIN9 and HIF1-α.

Authors:  Ulrike Begley; Maria Soledad Sosa; Alvaro Avivar-Valderas; Ashish Patil; Lauren Endres; Yeriel Estrada; Clement T Y Chan; Dan Su; Peter C Dedon; Julio A Aguirre-Ghiso; Thomas Begley
Journal:  EMBO Mol Med       Date:  2013-02-04       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.